About AtriCure, Inc.
https://www.atricure.comAtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
CEO
Michael H. Carrel
Compensation Summary
(Year 2021)
ETFs Holding This Stock
Summary
Showing Top 3 of 140
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:4.84M
Value:$180.9M
BLACKROCK INC.
Shares:4.62M
Value:$172.49M
WELLINGTON MANAGEMENT GROUP LLP
Shares:4.29M
Value:$160.4M
Summary
Showing Top 3 of 288
About AtriCure, Inc.
https://www.atricure.comAtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $134.27M ▼ | $101.12M ▼ | $-267K ▲ | -0.2% ▲ | $-0.01 ▲ | $7.99M ▲ |
| Q2-2025 | $136.14M ▲ | $107.67M ▲ | $-6.19M ▲ | -4.55% ▲ | $-0.13 ▲ | $732K ▲ |
| Q1-2025 | $123.62M ▼ | $98.58M ▼ | $-6.75M ▲ | -5.46% ▲ | $-0.14 ▲ | $-5.95M ▲ |
| Q4-2024 | $124.28M ▲ | $107.14M ▲ | $-15.57M ▼ | -12.53% ▼ | $-0.33 ▼ | $-9.03M ▼ |
| Q3-2024 | $115.91M | $94.2M | $-7.85M | -6.78% | $-0.17 | $-936K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $147.87M ▲ | $635.44M ▲ | $158.94M ▲ | $476.51M ▲ |
| Q2-2025 | $117.8M ▲ | $608.85M ▲ | $144.36M ▲ | $464.49M ▲ |
| Q1-2025 | $99.89M ▼ | $591.63M ▼ | $137.01M ▼ | $454.62M ▼ |
| Q4-2024 | $122.72M ▼ | $609.33M ▼ | $148.36M ▼ | $460.97M ▼ |
| Q3-2024 | $130.34M | $615.07M | $150.05M | $465.02M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-267K ▲ | $26.72M ▲ | $-2.6M ▲ | $5.98M ▲ | $30.07M ▲ | $24.11M ▲ |
| Q2-2025 | $-6.19M ▲ | $21.62M ▲ | $-7.66M ▼ | $3.42M ▲ | $17.91M ▲ | $13.96M ▲ |
| Q1-2025 | $-6.75M ▲ | $-11.03M ▼ | $-1.68M ▲ | $-10.32M ▼ | $-22.84M ▼ | $-13.21M ▼ |
| Q4-2024 | $-15.57M ▼ | $5.84M ▼ | $-14.69M ▼ | $1.74M ▲ | $-7.61M ▼ | $-8.86M ▼ |
| Q3-2024 | $-7.85M | $20M | $4.39M | $-333K | $24.3M | $16.4M |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $20.00M ▲ | $30.00M ▲ | $20.00M ▼ | $20.00M ▲ |
 US | $100.00M ▲ | $110.00M ▲ | $100.00M ▼ | $110.00M ▲ |
CEO
Michael H. Carrel
Compensation Summary
(Year 2021)
ETFs Holding This Stock
Summary
Showing Top 3 of 140
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:4.84M
Value:$180.9M
BLACKROCK INC.
Shares:4.62M
Value:$172.49M
WELLINGTON MANAGEMENT GROUP LLP
Shares:4.29M
Value:$160.4M
Summary
Showing Top 3 of 288